Tech Company Financing Transactions
TissueTech Funding Round
TissueTech, based in Miami, scored $82.3 million in investment from EW Healthcare Partners and Ballast Point Ventures.
Transaction Overview
Company Name
Announced On
6/27/2019
Transaction Type
Venture Equity
Amount
$82,250,000
Round
Series C
Investors
EW Healthcare Partners (Lead Investor) (Martin Sutter)
Proceeds Purpose
The funds will primarily be used to pursue regulatory approvals from the FDA for several of its development projects to comply with the agency's new guidance documents and support ongoing commercial development.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
7300 Corporate Center Dr. 700
Miami, FL 33126
USA
Miami, FL 33126
USA
Phone
Website
Email Address
Overview
Our mission is to develop and deliver high-quality and innovative regenerative wound healing solutions to eyecare providers and their patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Amy Tseng
Chief Financial Officer
Michael Cornelius
Chief Scientific Officer
Scheffer Tseng
VP - General Counsel
Devin Buckley
VP - Operations
Alan Petro
VP - Regulatory Affairs
Frank Young
Browse more venture capital transactions:
Prev: 6/27/2019: Orderful venture capital transaction
Next: 6/27/2019: Omada Health venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs